Financial Gravity Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Financial Gravity Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$2K	Buy	+102	New	+$1.91K	﹤0.01%	359
2019 Q4	–	Sell	-678	Closed	-$6K	–	1774
2019 Q3	$6K	Sell	678 -1,763	-72%	-$18.6K	0.01%	683
2019 Q2	$29K	Buy	+2,441	New	+$29.4K	0.02%	427
2018 Q3	$2K	Sell	101 -340	-77%	-$5.27K	﹤0.01%	1031
2018 Q2	$7K	Buy	441 +228	+107%	+$3.4K	0.01%	670
2018 Q1	$3K	Buy	+213	New	+$3.15K	﹤0.01%	900

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Gravity Asset Management's VIVO Position: Q4 2020 in Review

Financial Gravity Asset Management opened a new position in Meridian Bioscience Inc (VIVO) in Q4 2020: 102 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #359 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in VIVO as recently as Q3 2019.

Financial Gravity Asset Management first reported a position in VIVO in Q1 2018 and has held it in 6 quarters since. The position peaked at $29K in Q2 2019. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

Financial Gravity Asset Management held 102 shares of Meridian Bioscience Inc worth $2K as of Q4 2020.
Meridian Bioscience Inc was a new Financial Gravity Asset Management position in Q4 2020.
Meridian Bioscience Inc made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2020, its #359 holding.
Financial Gravity Asset Management first reported a position in Meridian Bioscience Inc in Q1 2018 and has held it in 6 quarters since.
Financial Gravity Asset Management's Meridian Bioscience Inc position peaked at $29K in Q2 2019.
192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on Financial Gravity Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.